Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec;35(12):1766-75.
doi: 10.1097/PAS.0b013e31822f58bc.

Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study

Affiliations

Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study

Kala Visvanathan et al. Am J Surg Pathol. 2011 Dec.

Abstract

There is compelling evidence that serous tubal intraepithelial carcinoma (STIC) is a precursor of high-grade serous ovarian carcinoma. Large-scale studies are now required to determine its biological significance and clinical implication. Before conducting these studies, a reproducible classification for STIC is needed, and that is the goal of this study. This study involved 6 gynecologic pathologists from 4 academic institutions and 3 independent rounds of review. In round 1, sixty-seven lesions ranging from normal, atypical, to STICs were classified by 5 pathologists on the basis of predetermined morphologic criteria. Interobserver agreement for the diagnosis of STIC versus not STIC was fair [κ = 0.39; 95% confidence interval (CI) 0.26, 0.52], and intraobserver reproducibility ranged from fair to moderate on the basis of percentage agreement and κ. Round 2 involved testing revised criteria that incorporated morphology and immunohistochemistry (IHC) for p53 protein expression and Ki-67 labeling in 10 sets by 3 of the pathologists. The result was an improvement in interobserver agreement for the classification of STIC (κ = 0.62; 95% CI 0.18, 1.00). An algorithm was then created combining morphology and IHC for p53 and Ki-67, and reproducibility was assessed as part of round 3. In 37 lesions reviewed by 6 pathologists, substantial agreement for STIC versus no STIC was observed (κ = 0.73; 95% CI 0.58, 0.86). In conclusion, we have developed reproducible criteria for the diagnosis of STIC that incorporate morphologic and IHC markers for p53 and Ki-67. The algorithm we propose is expected to help standardize the classification of STIC for future studies.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have disclosed that they have no significant relationships with, or financial interest in, any commercial companies pertaining to this article.

Figures

FIGURE 1
FIGURE 1
A flow chart describing the process that was undertaken to assess reproducibility of STIC.
FIGURE 2
FIGURE 2
Pathologic classification of fallopian tube lesions for rounds 1 to 3. A, Morphologic classification of fallopian tube lesions by each pathologist at 2 time points in round 1. B, Morphologic and immunohistochemical classification of fallopian tube lesions by each pathologist at 1 time point in round 2. C, Morphologic and immunohistochemical classification of fallopian tube lesions by each pathologist at 1 time point in round 3 based on the algorithm described in Figure 3. STIL indicates serous tubal intraepithelial lesion, STIC for serous tubal intraepithelial carcinoma and N/R indicates for normal/reactive. p53 signature is characterized by a strip of normal-appearing fallopian tube epithelium, at least 12 cells in length, which strongly expresses p53.
FIGURE 3
FIGURE 3
Algorithm for the diagnosis of STIC. Foci showing a Ki-67 labeling index >10% are considered Ki-67 high, whereas a Ki-67 labeling index of <10% is considered low. Diffuse moderate-to-strong expression of p53 in >75% of at least 12 epithelial cells (with or without intervening ciliated cells) or complete absence of staining has been shown to be compatible with a TP53 mutation either missense or nonsense (p53 MUT versus p53WT pattern in algorithm).
FIGURE 4
FIGURE 4
Final diagnosis of STIC by all 6 observers. Normal epithelium for comparison is present in the upper left corner. A, Morphologic designation of unequivocal STIC by all 6 observers. The epithelium is slightly stratified with loss of polarity and nuclear molding. A longitudinal cleft within the epithelium is present at the center of the photograph. The nuclei are enlarged with prominent nucleoli, and the nuclearto-cytoplasmic ratios are increased. B, The p53 immunostain was interpreted as “compatible with a TP53 mutation” by all 6 observers. C, High Ki-67 labeling index by all 6 observers.
FIGURE 5
FIGURE 5
Final diagnosis of STIL by all 6 observers. Normal epithelium for comparison is present in the lower left corner. A, Morphologic designation of suspicious for STIC by all 6 observers. The epithelium shows a suggestion of nuclear molding. Some nuclei are enlarged, rounded, and hyperchromatic; however, the overall morphologic features were not interpreted as sufficient for a morphologic designation of unequivocal STIC. B, The p53 immunostain was interpreted as “compatible with a TP53 mutation” by all 6 observers. C, Low-Ki-67 labeling index by all 6 observers.
FIGURE 6
FIGURE 6
Final diagnosis of normal/reactive by all 6 observers. Normal epithelium for comparison is present in the lower right corner. A, Morphologic designations of suspicious for STIC by 2 observers and not suspicious for STIC by 4 observers. The epithelium is slightly stratified, and the nuclei are questionably hyperchromatic. B, The p53 immunostain was interpreted as “NOT compatible with a TP53 mutation” by all 6 observers. C, Low-Ki-67 labeling index by all 6 observers.
FIGURE 7
FIGURE 7
Final diagnosis of p53 signature by all 6 observers. A, Morphologic designation of not suspicious for STIC by all 6 observers. Although no obviously ciliated cells are evident within the epithelium, no appreciable atypia is identified. B, The p53 immunostain was interpreted as “compatible with a TP53 mutation” by all 6 observers. C, Low-Ki-67 labeling index within the same segment showing a positive p53 pattern in (B) by all 6 observers.
FIGURE 8
FIGURE 8
Final diagnoses of STIC by 4 observers and STIL by 2 observers. A, Morphologic designations of unequivocal for STIC by 3 observers and suspicious for STIC by 3 observers. The epithelium is slightly stratified, and the nuclei are questionably enlarged and hyperchromatic. B, The p53 immunostain was interpreted as “compatible with a TP53 mutation” by all 6 observers. C, High Ki-67 labeling index by 4 observers and low-Ki-67 labeling index by 2 observers.

References

    1. Blegen H, Einhorn N, Sjovall K, et al. Prognostic significance of cell cycle proteins and genomic instability in borderline, early and advanced stage ovarian carcinomas. Int J Gynecol Cancer. 2000;10:477–487. - PubMed
    1. Carlson JW, Jarboe EA, Kindelberger D, et al. Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications. Int J Gynecol Pathol. 2010;29:310–314. - PubMed
    1. Davidson B, Skrede M, Silins I, et al. Low-molecular weight forms of cyclin E differentiate ovarian carcinoma from cells of mesothelial origin and are associated with poor survival in ovarian carcinoma. Cancer. 2007;110:1264–1271. - PubMed
    1. Jarboe E, Folkins A, Nucci MR, et al. Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol. 2008;27:1–9. - PubMed
    1. Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433–443. - PMC - PubMed

Publication types

MeSH terms